0001415889-24-003969.txt : 20240215
0001415889-24-003969.hdr.sgml : 20240215
20240215173854
ACCESSION NUMBER: 0001415889-24-003969
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20240214
FILED AS OF DATE: 20240215
DATE AS OF CHANGE: 20240215
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Hatzis-Schoch Brent
CENTRAL INDEX KEY: 0001637054
ORGANIZATION NAME:
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-39200
FILM NUMBER: 24645047
MAIL ADDRESS:
STREET 1: C/O RADIUS HEALTH, INC.
STREET 2: 950 WINTER STREET
CITY: WALTHAM
STATE: MA
ZIP: 02451
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Black Diamond Therapeutics, Inc.
CENTRAL INDEX KEY: 0001701541
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
ORGANIZATION NAME: 03 Life Sciences
IRS NUMBER: 000000000
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: ONE MAIN STREET, 14TH FLOOR
CITY: CAMBRIDGE
STATE: MA
ZIP: 02142
BUSINESS PHONE: 617-417-5868
MAIL ADDRESS:
STREET 1: ONE MAIN STREET, 14TH FLOOR
CITY: CAMBRIDGE
STATE: MA
ZIP: 02142
FORMER COMPANY:
FORMER CONFORMED NAME: Aset Therapeutics, Inc.
DATE OF NAME CHANGE: 20170321
4
1
form4-02152024_100242.xml
X0508
4
2024-02-14
0001701541
Black Diamond Therapeutics, Inc.
BDTX
0001637054
Hatzis-Schoch Brent
C/O BLACK DIAMOND THERAPEUTICS, INC.
ONE MAIN STREET, 14TH FLOOR
CAMBRIDGE
MA
02142
false
true
false
false
SEE REMARKS
0
Stock Option (Right to Buy)
4.86
2024-02-14
4
A
0
200000
0
A
2034-02-13
Common Stock
200000
200000
D
25% of the shares subject to this option shall vest and become exercisable on February 14, 2025, with the remainder vesting in 36 equal monthly installments thereafter.
Officer Title: Chief Operating Officer and General Counsel
/s/ Brent Hatzis-Schoch
2024-02-15